Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors

Endocrinology

Volumn 142, Issue 3, 2001, Pages 1290-1295

  Wei, Shi ^a   Teitelbaum, Steven L ^a   Wang, Michael W H ^a   Ross, F Patrick ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P50; SYNAPTOTAGMIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; STEM CELL; WESTERN BLOTTING;

EID: 0035092848     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.3.8031     Document Type: Article

References (38)

1. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
2. Recent advances in bone biology provide insight into the pathogenesis of bone diseases
3. Bone resorption by osteoclasts
4. Bone and haematopoietic defects in mice lacking c-fos
5. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
6. Targeted deletion of PU.1 induces osteopetrosis rescuable by bone marrow transplantation
7. Osteopetrosis in mice lacking NF-κB1 and NF-κB2
8. Requirement for NF-κB in osteoclast and B-cell development
9. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
10. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
11. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
12. CSF-1 signal transduction
13. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
14. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
15. RANKing the importance of measles in Paget's disease
16. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
17. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
18. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
19. 3 integrins are osteosclerotic due to dysfunctional osteoclasts
20. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages
21. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: Positive regulation by members of the rel/NF-κB family
22. The NF-κB and IκB proteins: New discoveries and insights
23. NF-κB: A lesson in family values
24. NF-κB activation: The IκB kinase revealed?
25. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
26. Tumor necrosis factor-α activation of nuclear transcription factor-κB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of IκBα
27. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
28. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1
29. Interleukin-1 alpha activates an NF-κB-like factor in osteoclast-like cells
30. Cytokines and estrogen in bone: Anti-osteoporotic effects
31. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
32. Cytokines, estrogen, and postmenopausal osteoporosis: The second decade
33. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
34. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
35. Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures
36. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
37. Tumor necrosis factor-α reduces differentiation of and bone resorption by osteoclasts
38. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand